: Both the safety and effectiveness of intrathecal tigecycline (TGC) for treatment of infections of the central nervous system (CNS) are discussed using the clinical findings from a study of a recent patient who came to our attention, along with a literature review. Although penetration into the CNS is low (approximately 11%), intraventricular TGC could help treat patients with severe post- neurosurgical CNS infections. The use of multiple routes of TGC administration appears to be encouraging and should be considered in managing life-threatening intraventricular infections.
Mastroianni, A., Vangeli, V., Mauro, M.V., Urso, F., Manfredi, R., Greco, S. (2023). Intrathecal tigecycline is a safe and effective treatment for central nervous system infections. ENCEPHALITIS, 3(3), 87-93 [10.47936/encephalitis.2023.00010].
Intrathecal tigecycline is a safe and effective treatment for central nervous system infections
Manfredi, Roberto;
2023
Abstract
: Both the safety and effectiveness of intrathecal tigecycline (TGC) for treatment of infections of the central nervous system (CNS) are discussed using the clinical findings from a study of a recent patient who came to our attention, along with a literature review. Although penetration into the CNS is low (approximately 11%), intraventricular TGC could help treat patients with severe post- neurosurgical CNS infections. The use of multiple routes of TGC administration appears to be encouraging and should be considered in managing life-threatening intraventricular infections.File | Dimensione | Formato | |
---|---|---|---|
encephalitis-2023-00010.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale (CCBYNC)
Dimensione
453.05 kB
Formato
Adobe PDF
|
453.05 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.